Literature DB >> 30824218

Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland.

Hanna-Maria Roitto1, Hannu Kautiainen2, Ulla L Aalto3, Hannareeta Öhman3, Jouko Laurila2, Kaisu H Pitkälä2.   

Abstract

OBJECTIVES: The use of psychotropic drugs in long-term care (LTC) is very common, despite their known adverse effects. The prevalence of opioid use is growing among older adults. This study aimed to investigate trends in the prevalence of psychotropics, opioids, and sedative load in a LTC setting over a 14-year period. We also explored the interaction of psychotropic and opioid use according to residents' dementia status in nursing home (NH) and assisted living facility (ALF) settings.
DESIGN: Four cross-sectional studies.
SETTING: Institutional settings in Helsinki, Finland. PARTICIPANTS: Older residents in NHs in 2003 (n = 1987), 2011 (n = 1576), and 2017 (n = 791) and in ALFs in 2007 (n = 1377), 2011 (n = 1586), and 2017 (n = 1624). MEASURES: Comparable assessments were conducted among LTC residents at 4 time points over 14 years. The prevalence of regular psychotropics, opioids, and other sedatives and data on demographics and diagnoses were collected from medical records.
RESULTS: Disabilities and severity of dementia increased in both settings over time. The prevalence of all psychotropics decreased significantly in NHs (from 81% in 2003 to 61% in 2017), whereas in ALFs there was no similar linear trend (65% in 2007 and 64% in 2017). There was a significant increase in the prevalence of opioids in both settings (30% in NHs and 22% in AFLs in 2017). Residents with dementia used less psychotropics and opioids than those without dementia in both settings and at each time point. CONCLUSIONS/IMPLICATIONS: NHs show a favorable trend in psychotropic drug use, but the rates of psychotropic use remain high in both NHs and ALFs. In addition, the rates of opioid use have almost tripled, leading to a high sedative load among LTC residents. Clinicians should carefully consider the risk-to-benefit ratio when prescribing in LTC.
Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Psychotropics; long-term care; nursing home; opioids; sedative load

Year:  2019        PMID: 30824218     DOI: 10.1016/j.jamda.2018.12.022

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  10 in total

1.  Prescription opioids among older adults: ten years of data across five countries.

Authors:  A Hamina; A E Muller; T Clausen; S Skurtveit; M Hesse; C Tjagvad; B Thylstrup; I Odsbu; H Zoega; H L Jónsdóttir; H Taipale
Journal:  BMC Geriatr       Date:  2022-05-16       Impact factor: 4.070

2.  The Use of Opioids and Antipsychotics in Elderly with Dementia - Have Opioids Replaced Antipsychotics in Treating Behavioral Symptoms in Dementia?

Authors:  Christina Jensen-Dahm; Ane Nørgaard Christensen; Christiane Gasse; Gunhild Waldemar
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki.

Authors:  Ulla L Aalto; Hanna-Maria Roitto; Harriet Finne-Soveri; Hannu Kautiainen; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

4.  Secular trends in functional abilities, health and psychological well-being among community-dwelling 75- to 95-year-old cohorts over three decades in Helsinki, Finland.

Authors:  Hanna R Öhman; Helena Karppinen; Tuuli E Lehti; Mia T Knuutila; Reijo Tilvis; Timo Strandberg; Hannu Kautiainen; Kaisu H Pitkala
Journal:  Scand J Public Health       Date:  2021-04-25       Impact factor: 3.199

5.  Correlates of Opioid Use Among Ontario Long-Term Care Residents and Variation by Pain Frequency and Intensity: A Cross-sectional Analysis.

Authors:  Anita Iacono; Michael A Campitelli; Susan E Bronskill; David B Hogan; Andrea Iaboni; Laura C Maclagan; Tara Gomes; Mina Tadrous; Charity Evans; Andrea Gruneir; Qi Guan; Thomas Hadjistavropoulos; Cecilia Cotton; Sudeep S Gill; Dallas P Seitz; Joanne Ho; Colleen J Maxwell
Journal:  Drugs Aging       Date:  2022-08-17       Impact factor: 4.271

6.  The effect of educational intervention on use of psychotropics in defined daily doses and related costs - a randomized controlled trial.

Authors:  Aalto Ulla L; Rantsi Mervi; Juola Anna-Liisa; Kautiainen Hannu; Pitkälä Kaisu H
Journal:  Scand J Prim Health Care       Date:  2022-05-12       Impact factor: 3.147

Review 7.  Psychometric properties of pain measurements for people living with dementia: a COSMIN systematic review.

Authors:  Toby O Smith; Karmen Harvey
Journal:  Eur Geriatr Med       Date:  2022-05-27       Impact factor: 3.269

8.  Incidence and type of restrictive practice use in nursing homes in Ireland.

Authors:  Paul Dunbar; Martin McMahon; Ciara Durkan; Kieran A Walsh; Laura M Keyes
Journal:  BMC Geriatr       Date:  2022-10-15       Impact factor: 4.070

Review 9.  Are Chronic Pain Patients with Dementia Being Undermedicated?

Authors:  Wilco P Achterberg; Ane Erdal; Bettina S Husebo; Miriam Kunz; Stefan Lautenbacher
Journal:  J Pain Res       Date:  2021-02-15       Impact factor: 3.133

10.  Prevalence of Musculoskeletal Pain and Analgesic Treatment Among Community-Dwelling Older Adults: Changes from 1999 to 2019.

Authors:  Tuuli Elina Lehti; M-O Rinkinen; U Aalto; H M Roitto; M Knuutila; H Öhman; H Kautiainen; H Karppinen; R Tilvis; T Strandberg; K H Pitkälä
Journal:  Drugs Aging       Date:  2021-08-13       Impact factor: 3.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.